Cardiac Marker Testing Market Worth $6.9 Billion : Investigating Research Trends, Industry Expansion, and Projections for 2028
In 2023, Bio-Rad launched the Bio-Plex 2300 Troponin I Assay, a new high-sensitivity troponin I test that can detect cardiac damage earlier than other troponin tests.
View full press release